Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

This study has been completed.
Information provided by (Responsible Party):
Bioniche Life Sciences Inc. Identifier:
First received: December 1, 2006
Last updated: July 26, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 28, 2013